• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌、益生元及抗氧化剂的体外筛选以研发一种创新型合生元(NatuREN G)并测试其对降低慢性肾脏病患者粪便样本中尿毒症毒素的效果。

In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients.

作者信息

Vacca Mirco, Celano Giuseppe, Lenucci Marcello Salvatore, Fontana Sergio, Forgia Flavia Maria la, Minervini Fabio, Scarano Aurelia, Santino Angelo, Dalfino Giuseppe, Gesualdo Loreto, De Angelis Maria

机构信息

Department of Soil Plant and Food Sciences, University of Bari, 70126 Bari, Italy.

Department of Biological and Environmental Science and Technologies, University of Salento, 73100 Lecce, Italy.

出版信息

Microorganisms. 2021 Jun 17;9(6):1316. doi: 10.3390/microorganisms9061316.

DOI:10.3390/microorganisms9061316
PMID:34204263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8235484/
Abstract

We aimed to develop an innovative synbiotic formulation for use in reducing dysbiosis, uremic toxins (e.g., -cresol and indoxyl sulfate), and, consequently, the pathognomonic features of patients with chronic kidney disease (CKD). Twenty-five probiotic strains, belonging to lactobacilli and , were tested for their ability to grow in co-culture with different vegetable (pomegranate, tomato, and grapes) sources of antioxidants and prebiotics (inulin, fructo-oligosaccharides, and β-glucans). Probiotics were selected based on the acidification rates and viable cell counts. Inulin and fructo-oligosaccharides reported the best prebiotic activity, while a pomegranate seed extract was initially chosen as antioxidant source. The investigation was also conducted in fecal batches from healthy and CKD subjects, on which metabolomic analyses (profiling volatile organic compounds and total free amino acids) were conducted. Two out of twenty-five probiotics were finally selected. After the stability tests, the selective innovative synbiotic formulation (named NatuREN G) comprised BLC1, LC4P1, fructo-oligosaccharides, inulin, quercetin, resveratrol, and proanthocyanidins. Finally, NatuREN G was evaluated on fecal batches collected from CKD in which modified the viable cell densities of some cultivable bacterial patterns, increased the concentration of acetic acid and decane, while reduced the concentration of nonanoic acid, dimethyl trisulfide, and indoxyl sulfate.

摘要

我们旨在开发一种创新的合生元配方,用于减少肠道菌群失调、尿毒症毒素(如对甲酚和硫酸吲哚酚),从而改善慢性肾脏病(CKD)患者的特征。对属于乳酸杆菌和双歧杆菌的25种益生菌菌株进行了测试,以评估它们与不同蔬菜(石榴、番茄和葡萄)来源的抗氧化剂和益生元(菊粉、低聚果糖和β-葡聚糖)共培养时的生长能力。根据酸化率和活菌计数选择益生菌。菊粉和低聚果糖具有最佳的益生元活性,而石榴籽提取物最初被选为抗氧化剂来源。研究还在健康受试者和CKD患者的粪便样本上进行,对其进行代谢组学分析(分析挥发性有机化合物和总游离氨基酸)。最终从25种益生菌中选出了两种。经过稳定性测试,最终确定的创新合生元配方(命名为NatuREN G)包含嗜酸乳杆菌BLC1、植物乳杆菌LC4P1、低聚果糖、菊粉、槲皮素、白藜芦醇和原花青素。最后,对从CKD患者收集的粪便样本进行了NatuREN G评估,结果显示该配方改变了一些可培养细菌模式的活菌密度,增加了乙酸和癸烷的浓度,同时降低了壬酸、二甲基三硫和硫酸吲哚酚的浓度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/630a104c2416/microorganisms-09-01316-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/e97c5f686f8b/microorganisms-09-01316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/e94682a8fa14/microorganisms-09-01316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/b1b92ebef729/microorganisms-09-01316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/eefac7898cc1/microorganisms-09-01316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/79282ba2e115/microorganisms-09-01316-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/3d65eb5eeb44/microorganisms-09-01316-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/f5c96a94c321/microorganisms-09-01316-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/0ac5ca9fdd31/microorganisms-09-01316-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/8ed813d78d07/microorganisms-09-01316-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/126a7bd1463b/microorganisms-09-01316-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/630a104c2416/microorganisms-09-01316-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/e97c5f686f8b/microorganisms-09-01316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/e94682a8fa14/microorganisms-09-01316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/b1b92ebef729/microorganisms-09-01316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/eefac7898cc1/microorganisms-09-01316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/79282ba2e115/microorganisms-09-01316-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/3d65eb5eeb44/microorganisms-09-01316-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/f5c96a94c321/microorganisms-09-01316-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/0ac5ca9fdd31/microorganisms-09-01316-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/8ed813d78d07/microorganisms-09-01316-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/126a7bd1463b/microorganisms-09-01316-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0579/8235484/630a104c2416/microorganisms-09-01316-g011.jpg

相似文献

1
In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients.益生菌、益生元及抗氧化剂的体外筛选以研发一种创新型合生元(NatuREN G)并测试其对降低慢性肾脏病患者粪便样本中尿毒症毒素的效果。
Microorganisms. 2021 Jun 17;9(6):1316. doi: 10.3390/microorganisms9061316.
2
In vitro fermentation of different fructo-oligosaccharides by Bifidobacterium strains for the selection of synbiotic combinations.双歧杆菌菌株对不同低聚果糖的体外发酵,用于筛选合生元组合。
Int J Food Microbiol. 2017 Feb 2;242:19-23. doi: 10.1016/j.ijfoodmicro.2016.11.011. Epub 2016 Nov 12.
3
Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.慢性肾脏病中益生元、益生菌和合生菌补充剂的应用:系统评价和荟萃分析。
J Ren Nutr. 2019 May;29(3):209-220. doi: 10.1053/j.jrn.2018.08.008. Epub 2018 Oct 23.
4
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients.一种创新性的共生元配方可降低 IIIb-IV 期 CKD 患者的游离血清吲哚硫酸酯、小肠通透性并改善胃肠道症状:一项随机先导试验研究。
Toxins (Basel). 2021 May 5;13(5):334. doi: 10.3390/toxins13050334.
5
Synbiotic effect of various prebiotics on in vitro activities of probiotic lactobacilli.多种益生元对益生菌乳酸杆菌体外活性的合生元效应。
Ecol Food Nutr. 2011 Jan-Feb;50(1):63-8. doi: 10.1080/03670244.2011.539161.
6
Effects of dietary prebiotics, probiotic and synbiotics on performance, caecal bacterial populations and caecal fermentation concentrations of broiler chickens.饲粮添加益生元、益生菌和合生元对肉鸡生产性能、盲肠细菌种群和盲肠发酵浓度的影响。
J Sci Food Agric. 2014 Jan 30;94(2):341-8. doi: 10.1002/jsfa.6365. Epub 2013 Sep 24.
7
Molecular assessment of the fecal microbiota in healthy cats and dogs before and during supplementation with fructo-oligosaccharides (FOS) and inulin using high-throughput 454-pyrosequencing.使用高通量454焦磷酸测序技术对健康猫和狗在补充低聚果糖(FOS)和菊粉之前及期间的粪便微生物群进行分子评估。
PeerJ. 2017 Apr 18;5:e3184. doi: 10.7717/peerj.3184. eCollection 2017.
8
Probiotic Bifidobacteria Mitigate the Deleterious Effects of -Cresol in a Drosophila melanogaster Toxicity Model.双歧杆菌益生菌减轻黑腹果蝇毒性模型中 - 甲酚的有害影响。
mSphere. 2022 Dec 21;7(6):e0044622. doi: 10.1128/msphere.00446-22. Epub 2022 Nov 2.
9
Effect of Bifidobacterium thermophilum RBL67 and fructo-oligosaccharides on the gut microbiota in Göttingen minipigs.嗜热双歧杆菌RBL67和低聚果糖对哥廷根小型猪肠道微生物群的影响。
Br J Nutr. 2015 Sep 14;114(5):746-55. doi: 10.1017/S0007114515002263.
10
Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.益生菌双歧杆菌株和半乳糖寡糖可改善肥胖成年人的肠道屏障功能,但作为合生元使用时没有协同作用。
Microbiome. 2018 Jun 28;6(1):121. doi: 10.1186/s40168-018-0494-4.

引用本文的文献

1
Optimizing chronic kidney disease management: The potential of a multi-strain probiotic formulation.优化慢性肾脏病管理:多菌株益生菌制剂的潜力。
World J Nephrol. 2025 Mar 25;14(1):101515. doi: 10.5527/wjn.v14.i1.101515.
2
Phenolic characterization and nutraceutical evaluation of by-products from different globe artichoke cultivars.不同球茎甘蓝品种副产物的酚类物质表征及营养评价
J Sci Food Agric. 2025 Jul;105(9):5062-5073. doi: 10.1002/jsfa.14232. Epub 2025 Mar 22.
3
Future of Uremic Toxin Management.尿毒症毒素管理的未来。

本文引用的文献

1
Selection of Gut-Resistant Bacteria and Construction of Microbial Consortia for Improving Gluten Digestion under Simulated Gastrointestinal Conditions.在模拟胃肠道条件下改善谷蛋白消化的耐胃酸细菌的选择和微生物群落的构建。
Nutrients. 2021 Mar 19;13(3):992. doi: 10.3390/nu13030992.
2
Ketoanalogs' Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study).酮类似物对慢性肾脏病肠道微生物群调节及尿毒症毒素血清水平的影响(Medika2研究)
J Clin Med. 2021 Feb 18;10(4):840. doi: 10.3390/jcm10040840.
3
Effects of short chain fatty acids on metabolic and inflammatory processes in human health.
Toxins (Basel). 2024 Oct 28;16(11):463. doi: 10.3390/toxins16110463.
4
Biotics (Pre-, Pro-, Post-) and Uremic Toxicity: Implications, Mechanisms, and Possible Therapies.生物制剂(前、中、后)与尿毒症毒素:影响、机制及可能的治疗方法。
Toxins (Basel). 2023 Sep 4;15(9):548. doi: 10.3390/toxins15090548.
5
Bergamot Polyphenolic Extract Combined with Albedo and Pulp Fibres Counteracts Changes in Gut Microbiota Associated with High-Fat Diet: Implications for Lipoprotein Size Re-Arrangement.佛手多酚提取物联合白柳皮和果肉纤维可逆转高脂肪饮食相关的肠道菌群变化:对脂蛋白大小重排的影响。
Int J Mol Sci. 2023 Aug 19;24(16):12967. doi: 10.3390/ijms241612967.
6
evaluation of an innovative synbiotics on stage IIIb-IV chronic kidney disease patients.对创新型合生元制剂用于IIIb-IV期慢性肾病患者的评估。
Front Nutr. 2023 Jun 15;10:1215836. doi: 10.3389/fnut.2023.1215836. eCollection 2023.
7
Gluten-Free Bread Enriched with Artichoke Leaf Extract In Vitro Exerted Antioxidant and Anti-Inflammatory Properties.富含洋蓟叶提取物的无麸质面包在体外具有抗氧化和抗炎特性。
Antioxidants (Basel). 2023 Apr 1;12(4):845. doi: 10.3390/antiox12040845.
8
The Chelating Ability of Plant Polyphenols Can Affect Iron Homeostasis and Gut Microbiota.植物多酚的螯合能力会影响铁稳态和肠道微生物群。
Antioxidants (Basel). 2023 Mar 3;12(3):630. doi: 10.3390/antiox12030630.
9
Special Issue "How Do Food and Probiotics Influence the Composition and Activity of the Gut Microbiota?".特刊“食物和益生菌如何影响肠道微生物群的组成和活性?”
Microorganisms. 2022 Oct 22;10(11):2097. doi: 10.3390/microorganisms10112097.
10
Inulin from Globe Artichoke Roots: A Promising Ingredient for the Production of Functional Fresh Pasta.洋蓟根中的菊粉:一种用于生产功能性新鲜面食的有前景的成分。
Foods. 2022 Sep 30;11(19):3032. doi: 10.3390/foods11193032.
短链脂肪酸对人类健康中代谢和炎症过程的影响。
Biochim Biophys Acta Mol Cell Biol Lipids. 2021 May;1866(5):158900. doi: 10.1016/j.bbalip.2021.158900. Epub 2021 Feb 9.
4
Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial.低聚果糖对慢性肾脏病患者血管内皮功能的影响:一项随机对照试验。
Nephrol Dial Transplant. 2021 Dec 31;37(1):85-91. doi: 10.1093/ndt/gfaa335.
5
Bioactive compounds, antioxidant and antimicrobial activities of extracts from different plant parts of two Ziziphus Mill. species.两种枣属植物不同部位提取物的生物活性化合物、抗氧化和抗菌活性。
PLoS One. 2020 May 19;15(5):e0232599. doi: 10.1371/journal.pone.0232599. eCollection 2020.
6
Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease.在乳糜泻中,对肠道微生物群和益生菌介导疗法潜在治疗应用的理解进展。
Expert Rev Gastroenterol Hepatol. 2020 May;14(5):323-333. doi: 10.1080/17474124.2020.1745630. Epub 2020 Mar 27.
7
Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients.慢性肾脏病患者中产生尿毒症毒素前体的肠道细菌的分离和定量。
Int J Mol Sci. 2020 Mar 14;21(6):1986. doi: 10.3390/ijms21061986.
8
Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.肠道微生物群与慢性肾脏病:介导胃肠-肾轴新通讯的证据和机制。
Pflugers Arch. 2020 Mar;472(3):303-320. doi: 10.1007/s00424-020-02352-x. Epub 2020 Feb 17.
9
Extraction and characterization of phenolic compounds with antioxidant and antimicrobial activities from pickled radish.从腌制萝卜中提取具有抗氧化和抗菌活性的酚类化合物并进行其特性分析。
Food Chem Toxicol. 2020 Feb;136:111050. doi: 10.1016/j.fct.2019.111050. Epub 2019 Dec 14.
10
Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study).营养疗法调节慢性肾脏病患者的肠道微生物群并降低血清总硫酸吲哚酚和游离硫酸吲哚酚以及对甲酚硫酸酯水平(Medika研究)。
J Clin Med. 2019 Sep 10;8(9):1424. doi: 10.3390/jcm8091424.